EUVIMEDEUVIMED entdecken
LeserbriefMultizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Machine learning and radiomics for predicting efficacy of programmed cell death protein 1 inhibitor for small cell lung cancer: A multicenter cohort study

Pulin Li, Ling Huang, Rui Han, Min Tang, Guanghe Fei, Daxiong Zeng, Ran Wang iD

Clinical and Translational Medicine · 2024-06 · 14 (6)

DOI: 10.1002/ctm2.1673 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Translational Medicine, online erschienen am 05.06.2024. Verfasst von Pulin Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Machine Learning, Small Cell Lung Carcinoma, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Fund project of Anhui Medical University, Research Fund of Anhui Institute of translational medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningSmall Cell Lung CarcinomaLung NeoplasmsHumansMaleCohort StudiesFemaleMiddle AgedAgedImmune Checkpoint InhibitorsTreatment OutcomeProgrammed Cell Death 1 ReceptorRadiomics

Substanzen

Immune Checkpoint InhibitorsProgrammed Cell Death 1 Receptor

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, the First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Department of Infectious Disease, Hefei Second People's Hospital, Hefei, China.
  • Department of Pulmonary and Critical Care Medicine, Medical Center of Soochow University, Dushu Lake Hospital Affiliated to Soochow University, Suzhou, China.

ORCID-Profile: Ran Wang

Förderung

  • Research Fund project of Anhui Medical University
  • Research Fund of Anhui Institute of translational medicine

Zitieren

APA

Li, P., Huang, L., Han, R., Tang, M., Fei, G., Zeng, D., & Wang, R. (2024). Machine learning and radiomics for predicting efficacy of programmed cell death protein 1 inhibitor for small cell lung cancer: A multicenter cohort study. Clinical and Translational Medicine, 14(6). https://doi.org/10.1002/ctm2.1673

Vancouver

Li P, Huang L, Han R, Tang M, Fei G, Zeng D, et al. Machine learning and radiomics for predicting efficacy of programmed cell death protein 1 inhibitor for small cell lung cancer: A multicenter cohort study. Clinical and Translational Medicine. 2024;14(6). doi:10.1002/ctm2.1673

BibTeX
@article{Li2024,
  author = {Li, Pulin and Huang, Ling and Han, Rui and Tang, Min and Fei, Guanghe and Zeng, Daxiong and Wang, Ran},
  title = {Machine learning and radiomics for predicting efficacy of programmed cell death protein 1 inhibitor for small cell lung cancer: A multicenter cohort study},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  volume = {14},
  number = {6},
  doi = {10.1002/ctm2.1673}
}
Kostenlos starten →